• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

足细胞 NLRP3 炎性小体的激活导致狼疮肾炎蛋白尿的发生。

Podocyte Activation of NLRP3 Inflammasomes Contributes to the Development of Proteinuria in Lupus Nephritis.

机构信息

First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

出版信息

Arthritis Rheumatol. 2017 Aug;69(8):1636-1646. doi: 10.1002/art.40155. Epub 2017 Jun 26.

DOI:10.1002/art.40155
PMID:28544564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5568813/
Abstract

OBJECTIVE

Development of proteinuria in lupus nephritis (LN) is associated with podocyte dysfunction. The NLRP3 inflammasome has been implicated in the pathogenesis of LN. The purpose of this study was to investigate whether NLRP3 inflammasome activation is involved in the development of podocyte injury in LN.

METHODS

A fluorescence-labeled caspase 1 inhibitor probe was used to detect the activation of NLRP3 inflammasomes in podocytes derived from lupus-prone NZM2328 mice and from renal biopsy tissues obtained from patients with LN. MCC950, a selective inhibitor of NLRP3, was used to treat NZM2328 mice. Proteinuria, podocyte ultrastructure, and renal pathology were evaluated. In vitro, sera from diseased NZM2328 mice were used to stimulate a podocyte cell line, and the cells were analyzed by flow cytometry.

RESULTS

NLRP3 inflammasomes were activated in podocytes from lupus-prone mice and from patients with LN. Inhibition of NLRP3 with MCC950 ameliorated proteinuria, renal histologic lesions, and podocyte foot process effacement in lupus-prone mice. In vitro, sera from diseased NZM2328 mice activated NLRP3 inflammasomes in the podocyte cell line through the production of reactive oxygen species.

CONCLUSION

NLRP3 inflammasomes were activated in podocytes from lupus-prone mice and from LN patients. Activation of NLRP3 is involved in the pathogenesis of podocyte injuries and the development of proteinuria in LN.

摘要

目的

狼疮肾炎(LN)患者的蛋白尿发展与足细胞功能障碍有关。NLRP3 炎性小体与 LN 的发病机制有关。本研究旨在探讨 NLRP3 炎性小体的激活是否参与 LN 中足细胞损伤的发生。

方法

使用荧光标记的半胱天冬酶 1 抑制剂探针检测狼疮易感 NZM2328 小鼠来源的足细胞和 LN 患者肾活检组织中 NLRP3 炎性小体的激活。使用 NLRP3 的选择性抑制剂 MCC950 治疗 NZM2328 小鼠。评估蛋白尿、足细胞超微结构和肾脏病理。在体外,使用来自患病 NZM2328 小鼠的血清刺激足细胞系,并通过流式细胞术分析细胞。

结果

NLRP3 炎性小体在狼疮易感小鼠和 LN 患者的足细胞中被激活。用 MCC950 抑制 NLRP3 可改善狼疮易感小鼠的蛋白尿、肾脏组织学病变和足细胞足突融合。在体外,来自患病 NZM2328 小鼠的血清通过产生活性氧来激活足细胞系中的 NLRP3 炎性小体。

结论

NLRP3 炎性小体在狼疮易感小鼠和 LN 患者的足细胞中被激活。NLRP3 的激活参与了 LN 中足细胞损伤和蛋白尿发展的发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb7f/5568813/75cc08ee907b/nihms877381f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb7f/5568813/dbabe7b0549d/nihms877381f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb7f/5568813/b3fb4dea1e05/nihms877381f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb7f/5568813/abbd0e315620/nihms877381f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb7f/5568813/3373e815c571/nihms877381f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb7f/5568813/cbfc172bf501/nihms877381f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb7f/5568813/75cc08ee907b/nihms877381f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb7f/5568813/dbabe7b0549d/nihms877381f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb7f/5568813/b3fb4dea1e05/nihms877381f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb7f/5568813/abbd0e315620/nihms877381f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb7f/5568813/3373e815c571/nihms877381f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb7f/5568813/cbfc172bf501/nihms877381f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb7f/5568813/75cc08ee907b/nihms877381f6.jpg

相似文献

1
Podocyte Activation of NLRP3 Inflammasomes Contributes to the Development of Proteinuria in Lupus Nephritis.足细胞 NLRP3 炎性小体的激活导致狼疮肾炎蛋白尿的发生。
Arthritis Rheumatol. 2017 Aug;69(8):1636-1646. doi: 10.1002/art.40155. Epub 2017 Jun 26.
2
Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.NLRP3 炎性小体抑制可通过抑制脂滴蓄积改善糖尿病肾病足细胞损伤。
Metabolism. 2021 May;118:154748. doi: 10.1016/j.metabol.2021.154748. Epub 2021 Mar 4.
3
Pathogenesis of lupus nephritis: RIP3 dependent necroptosis and NLRP3 inflammasome activation.狼疮肾炎的发病机制:RIP3 依赖性坏死性凋亡和 NLRP3 炎性小体激活。
J Autoimmun. 2019 Sep;103:102286. doi: 10.1016/j.jaut.2019.05.014. Epub 2019 May 24.
4
Blockade of Notch1 Signaling Alleviated Podocyte Injury in Lupus Nephritis Via Inhibition of NLRP3 Inflammasome Activation.阻断 Notch1 信号通路通过抑制 NLRP3 炎性小体激活减轻狼疮肾炎足细胞损伤。
Inflammation. 2024 Apr;47(2):649-663. doi: 10.1007/s10753-023-01935-x. Epub 2023 Dec 12.
5
Lupus nephritis: glycogen synthase kinase 3β promotion of renal damage through activation of the NLRP3 inflammasome in lupus-prone mice.狼疮肾炎:糖原合酶激酶 3β 通过激活狼疮易感小鼠中的 NLRP3 炎性体促进肾损伤。
Arthritis Rheumatol. 2015 Apr;67(4):1036-44. doi: 10.1002/art.38993.
6
Activation of Nod-like receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia.Nod 样受体蛋白 3 炎性小体的激活导致高同型半胱氨酸血症中足细胞损伤和肾小球硬化。
Hypertension. 2012 Jul;60(1):154-62. doi: 10.1161/HYPERTENSIONAHA.111.189688. Epub 2012 May 29.
7
NLRP3 Inflammasome and Mineralocorticoid Receptors Are Associated with Vascular Dysfunction in Type 2 Diabetes Mellitus.NLRP3 炎性小体和盐皮质激素受体与 2 型糖尿病血管功能障碍有关。
Cells. 2019 Dec 8;8(12):1595. doi: 10.3390/cells8121595.
8
Renal NLRP3 Inflammasome activation is associated with disease activity in lupus nephritis.肾脏 NLRP3 炎性小体激活与狼疮肾炎的疾病活动有关。
Clin Immunol. 2023 Feb;247:109221. doi: 10.1016/j.clim.2022.109221. Epub 2023 Jan 4.
9
CD36 aggravates podocyte injury by activating NLRP3 inflammasome and inhibiting autophagy in lupus nephritis.CD36 通过激活 NLRP3 炎症小体和抑制自噬加重狼疮肾炎足细胞损伤。
Cell Death Dis. 2022 Aug 23;13(8):729. doi: 10.1038/s41419-022-05179-9.
10
Podocyte NLRP3 Inflammasome Activation and Formation by Adipokine Visfatin.脂肪因子内脂素激活和形成足细胞NLRP3炎性小体
Cell Physiol Biochem. 2019;53(2):355-365. doi: 10.33594/000000143.

引用本文的文献

1
Ultrasound combined with microbubble enhanced renoprotective effects of NLRP3 inflammasome inhibitor MCC950 in CKD model.超声联合微泡增强NLRP3炎性小体抑制剂MCC950在慢性肾脏病模型中的肾脏保护作用
Front Pharmacol. 2025 Jul 31;16:1616542. doi: 10.3389/fphar.2025.1616542. eCollection 2025.
2
SGLT2 inhibitors in autoimmune diseases: emerging therapeutic potential and clinical challenges.钠-葡萄糖协同转运蛋白2抑制剂在自身免疫性疾病中的应用:新出现的治疗潜力与临床挑战
Front Immunol. 2025 Jul 3;16:1589341. doi: 10.3389/fimmu.2025.1589341. eCollection 2025.
3
Targeting the NLRP3 inflammasome for calcium oxalate stones: pathophysiology and emerging pharmacological interventions.

本文引用的文献

1
Dependence of Glomerulonephritis Induction on Novel Intraglomerular Alternatively Activated Bone Marrow-Derived Macrophages and Mac-1 and PD-L1 in Lupus-Prone NZM2328 Mice.狼疮易感 NZM2328 小鼠中肾小球肾炎诱导对新型肾小球内交替活化的骨髓来源巨噬细胞以及 Mac-1 和 PD-L1 的依赖性
J Immunol. 2017 Apr 1;198(7):2589-2601. doi: 10.4049/jimmunol.1601565. Epub 2017 Feb 20.
2
Mitochondrial function is required for extracellular ATP-induced NLRP3 inflammasome activation.细胞外ATP诱导NLRP3炎性小体激活需要线粒体功能。
J Biochem. 2017 Jun 1;161(6):503-512. doi: 10.1093/jb/mvw098.
3
Inflammasomes in the Pathophysiology of Kidney Diseases.
靶向NLRP3炎性小体治疗草酸钙结石:病理生理学及新兴的药理学干预措施
Front Physiol. 2025 Jun 3;16:1614438. doi: 10.3389/fphys.2025.1614438. eCollection 2025.
4
Traditional Chinese medicine for lupus nephritis: modulation of autoimmune pathogenesis.用于狼疮性肾炎的中药:自身免疫发病机制的调节
Front Pharmacol. 2025 May 2;16:1523272. doi: 10.3389/fphar.2025.1523272. eCollection 2025.
5
Podocyte A20/TNFAIP3 Controls Glomerulonephritis Severity via the Regulation of Inflammatory Responses and Effects on the Cytoskeleton.足细胞A20/TNFAIP3通过调节炎症反应和对细胞骨架的作用来控制肾小球肾炎的严重程度。
Cells. 2025 Mar 5;14(5):381. doi: 10.3390/cells14050381.
6
Clinical presentation, outcomes and risk of relapses of lupus podocytopathy in a multicentre Italian cohort.意大利多中心队列中狼疮性足细胞病的临床表现、结局及复发风险
J Nephrol. 2025 Mar;38(2):643-653. doi: 10.1007/s40620-024-02178-1. Epub 2025 Jan 30.
7
The Role of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors in Treating Lupus Nephritis: A Systematic Review.钠-葡萄糖协同转运蛋白2(SGLT-2)抑制剂在治疗狼疮性肾炎中的作用:一项系统评价
Cureus. 2024 Dec 21;16(12):e76130. doi: 10.7759/cureus.76130. eCollection 2024 Dec.
8
The Role of Podocytes in Lupus Pathology.足细胞在狼疮病理学中的作用。
Curr Rheumatol Rep. 2024 Dec 28;27(1):10. doi: 10.1007/s11926-024-01175-4.
9
Novel approach to alleviate lupus nephritis: targeting the NLRP3 inflammasome in CD8CD69CD103 T cells.缓解狼疮性肾炎的新方法:靶向CD8CD69CD103 T细胞中的NLRP3炎性小体
J Transl Med. 2024 Dec 23;22(1):1139. doi: 10.1186/s12967-024-05951-9.
10
Podocyte Injury and Long-Term Kidney Prognosis in Patients with Lupus Nephritis.狼疮性肾炎患者的足细胞损伤与肾脏长期预后
Kidney360. 2025 Apr 1;6(4):606-615. doi: 10.34067/KID.0000000688. Epub 2024 Dec 23.
炎性小体在肾脏疾病发病机制中的作用
Kidney Dis (Basel). 2015 Dec;1(3):187-93. doi: 10.1159/000438843. Epub 2015 Sep 4.
4
NLRP3 Localizes to the Tubular Epithelium in Human Kidney and Correlates With Outcome in IgA Nephropathy.NLRP3定位于人肾脏的肾小管上皮细胞,且与IgA肾病的预后相关。
Sci Rep. 2016 Apr 20;6:24667. doi: 10.1038/srep24667.
5
The NLRP3 inflammasome in kidney disease and autoimmunity.肾病和自身免疫中的NLRP3炎性小体
Nephrology (Carlton). 2016 Sep;21(9):736-44. doi: 10.1111/nep.12785.
6
Lupus Nephritis IgG Induction of Calcium/Calmodulin-Dependent Protein Kinase IV Expression in Podocytes and Alteration of Their Function.狼疮性肾炎 IgG 诱导足细胞钙/钙调蛋白依赖性蛋白激酶 IV 的表达及其功能改变。
Arthritis Rheumatol. 2016 Apr;68(4):944-52. doi: 10.1002/art.39499.
7
The Expression and Significance of NLRP3 Inflammasome in Patients with Primary Glomerular Diseases.NLRP3炎性小体在原发性肾小球疾病患者中的表达及意义
Kidney Blood Press Res. 2015;40(4):344-54. doi: 10.1159/000368511. Epub 2015 Jun 20.
8
Podocyte injury and repair mechanisms.足细胞损伤与修复机制。
Curr Opin Nephrol Hypertens. 2015 May;24(3):239-44. doi: 10.1097/MNH.0000000000000124.
9
Role of NLRP3 Inflammasomes for Rhabdomyolysis-induced Acute Kidney Injury.NLRP3炎性小体在横纹肌溶解诱导的急性肾损伤中的作用
Sci Rep. 2015 Jun 5;5:10901. doi: 10.1038/srep10901.
10
Inflammasomes and human autoimmunity: A comprehensive review.炎性小体与人类自身免疫病:全面综述。
J Autoimmun. 2015 Jul;61:1-8. doi: 10.1016/j.jaut.2015.05.001. Epub 2015 May 23.